Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01919177 · ClinicalTrials.gov registry record · Phase 2
Effect of Inorganic Nitrates (Beetroot Juice) on Arterial Hemodynamics and Exercise Capacity
A Phase 2 study of Heart Failure With Normal Ejection Fraction, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT01919177 is a Phase 2 study of Heart Failure With Normal Ejection Fraction that has completed, run by Corporal Michael J. Crescenz VA Medical Center. The registered enrollment target is 17 participants, below the 638-participant average among 10 other Heart Failure With Normal Ejection Fraction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01919177, a Phase 2 study of Heart Failure With Normal Ejection Fraction, has completed, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective is to test the hypothesis that inorganic nitrate supplementation will: (1) Improve exercise efficiency and performance; (2) Enhance the systemic vasodilator reserve during exercise and specifically, the vasodilator response in exercising muscle; (3) Reduce arterial wave reflections and arterial load; (4) Improve skeletal muscle mitochondrial function in subjects with heart failure with preserved ejection fraction.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Nitrate rich beetroot juice
- DIETARY_SUPPLEMENT Nitrate depleted beetroot juice
Study Locations (1)
Pennsylvania
- Philadelphia Veterans Affairs Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01919177
The ClinicalTrials.gov registry entry for NCT01919177 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 638-participant average among 10 other Heart Failure With Normal Ejection Fraction trials with a reported enrollment target (97% lower). The listed sponsor is Corporal Michael J. Crescenz VA Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure With Normal Ejection Fraction appearing as the primary indexed condition, and to 2 interventions - of which Nitrate rich beetroot juice is the first listed.
NCT01919177 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01919177 about?
NCT01919177 is a clinical study titled "Effect of Inorganic Nitrates (Beetroot Juice) on Arterial Hemodynamics and Exercise Capacity". The main objective is to test the hypothesis that inorganic nitrate supplementation will: (1) Improve exercise efficiency and performance; (2) Enhance the systemic vasodilator reserve during exercise and specifically, the vasodilator response in exercising muscle; (3) Reduce arterial wave reflection...
What is the current status of trial NCT01919177?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2013-01. Estimated completion is 2014-11.
What conditions does trial NCT01919177 study?
This clinical trial studies the following conditions: Heart Failure With Normal Ejection Fraction.
What interventions are being tested in trial NCT01919177?
The interventions under investigation include: Nitrate rich beetroot juice (DIETARY_SUPPLEMENT), Nitrate depleted beetroot juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01919177?
This trial is sponsored by Corporal Michael J. Crescenz VA Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01919177 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Normal Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
COMPLETED · Phase 2
-
Exercise Intolerance in Heart Failure
RECRUITING
-
New Orleans Pulmonary Hypertension Biobank
RECRUITING
-
Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
RECRUITING
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.